Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to download here. In 2025, the strategy returned +3.1% (gross) and +3.0% (net), resulting in the year-to-date return of 16.7% (gross) and +16.0% (net). Discussions on a potential bubble in Artificial Intelligence (AI) markets were a significant feature of 2025, especially in Q4, contributing to a pullback in AI stocks as investors expressed fears of an upcoming downturn. President Trump’s erratic trade and foreign policies were another challenge faced by the market in 2025. In addition, you can check the Strategy’s top 5 holdings to determine its best picks for 2025.
In its fourth-quarter 2025 investor letter, Emerald Growth Equity Strategy highlighted stocks like Revvity, Inc. (NYSE:RVTY). Revvity, Inc. (NYSE:RVTY) is an American company that provides health sciences solutions, technologies, and services. On March 13, 2026, Revvity, Inc. (NYSE:RVTY) stock closed at $85.62 per share. One-month return of Revvity, Inc. (NYSE:RVTY) was -8.72%, and its shares lost 22.57% over the past 52 weeks. Revvity, Inc. (NYSE:RVTY) has a market capitalization of $9.924 billion.
Emerald Growth Equity Strategy stated the following regarding Revvity, Inc. (NYSE:RVTY) in its fourth quarter 2025 investor letter:
“We used a rebound in Revvity, Inc. (NYSE:RVTY) during Q4 to exit the position. Limited visibility into the company’s business trajectory, combined with management’s failure to deliver on key elements of its strategic plan, led us to conclude that the risk–reward profile was no longer compelling.”
Revvity, Inc. (NYSE:RVTY) is not on our list of 40 Most Popular Stocks Among Hedge Funds. According to our database, 35 hedge fund portfolios held Revvity, Inc. (NYSE:RVTY) at the end of the fourth quarter, up from 22 in the previous quarter. While we acknowledge the potential of Revvity, Inc. (NYSE:RVTY) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In another article, we covered Revvity, Inc. (NYSE:RVTY) and shared Bretton Fund’s views on the company. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
